Reacción #167802

ord-d4de5653a6114a0aa151d893f9fa0dbb

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    OtroThe product is prepared
  2. 2
    OtroAfter purification by preparative HPLC/MS (Method C), 86 mg of (8S)-9-(2,4-difluorobenzyl)-2-(morpholin-4-yl)-8-(trifluoromethyl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one
  3. 3
    Otroare obtained in the form of an oil

Procedimiento

The product is prepared according to the procedure described in Example 22, using 100 mg of (8S)-2-morpholin-4-yl-8-trifluoromethyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one (Example 1e), 214 mg of caesium carbonate and 75 mg of 1-(bromomethyl)-2,4-difluorobenzene in 2 ml of dimethylformamide. After purification by preparative HPLC/MS (Method C), 86 mg of (8S)-9-(2,4-difluorobenzyl)-2-(morpholin-4-yl)-8-(trifluoromethyl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one are obtained in the form of an oil, the characteristics of which are the following:

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US08846670B2uspto-grants-2014_09